You are here

A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Ottawa Allergy Research Corporation
Ottawa, Ontario, K1Y 4G2 Canada
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Allergic Rhinitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy, males or females of non-child bearing potential, who are between 18 and 55
years, inclusive,

- Intermittent or persistent allergic rhinitis that is associated with perennial or
seasonal allergen reactivity at screening as determined by a positive specific IgE
level ≥1 KU/L to at least one of the following common allergens: dust mite
(Dermatophagoides farinae or Dermatophagoides pteronyssinus), cat, dog, mold
(Alternaria), Bermuda grass, common ragweed, oak, Timothy grass or elm.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence or history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, or neurologic
disease that may compromise their ability to safely participate in the study.

- Evidence or history of clinically significant pulmonary disease (including allergic
and non-allergic asthma, chronic obstructive pulmonary disease [COPD], cystic
fibrosis, bronchiectasis, chronic bronchitis, emphysema, tuberculosis, pulmonary
fibrosis, pulmonary hypertension, or others).

- Evidence or history of clinically significant autoimmune disease (including rheumatoid
arthritis, systemic lupus erythematosus, ulcerative colitis, or others).

NCT01723254
Pfizer
Completed
A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now